Release Therapeutics
Biotechnology Research
Geneve, Genève, Ch
5 employees
- Employees
- 5
- Contacts
- 2
- Emails
- 2
Release Therapeutics Overview
- Headquarters
- Geneve, Genève, Ch
- Website
- maxivax.ch
- Industry
- Biotechnology Research
- Employees
- 5
- Founded
- 2005
- Funding
- 3.9M
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About Release Therapeutics
Release Therapeutics is a preclinical-stage BioMedTech company developing the first cell macroencapsulation technology designed to deliver potent therapeutic proteins beyond the human blood-brain barrier.
Release Therapeutics Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Release Therapeutics Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Julien Grogg | Bridging Concept to Patient Impact ⎮ | Switzerland |
View
|
| T Scott Johnson | Co-founder and CEO at Comanche Biopharma | Concord, Massachusetts, United States |
Email
|
| Nicolas Mach | Médecin Adjoint Dans Le Service |
View
|
|
| Adrien Engel | Preclinical Scientist - R&D | Lausanne, Vaud, Switzerland |
Email
|
Employees by Management Level
Individual contributor
3 profiles
Executive
1 profile
Compare Similar Companies to Release Therapeutics
Borealis Biosciences, Inc.
Biotechnology Research
Ambrosia Biosciences Inc.
Biotechnology Research
Biomatter
Biotechnology Research
Talus Bio
Biotechnology Research
Diakonos Oncology
Pharmaceutical Manufacturing
Kinoxis Therapeutics Pty Ltd
Biotechnology Research
Nygen Analytics
Biotechnology Research
PITTAN
Hospitals And Health Care
CrossPoint Therapeutics
Biotechnology Research
Nob Hill Therapeutics
Biotechnology Research